Dysfunction of the IRS/Akt/FOXO pathway due to selective hepatic insulin resistance results in a loss of inhibition of Apo B lipidation, contributing to a significant increase in the secretion of Apo B-containing lipoproteins, such as VLDL [130]. The gene discussed is APOB; the disease is Insulin resistance.